IBM heads into its third-quarter report with a credibility question more than an earnings question. Three months ago, the company pre-announced a revenue shortfall and blamed tens of large enterprise license and capital-spending deals that slipped in the final weeks of June, as clients rushed to lock in supply-constrained servers, storage and memory ahead of price hikes. Management insisted the demand was deferred, not destroyed, and said roughly a third to 40% of those deals closed in the first three weeks of the new quarter. The October 21 release, due after the close, is the first real chance to check that claim against the numbers.

The Street is looking for earnings of $2.87 a share on revenue of $16.84 billion, which would mean roughly 8% EPS growth and about 3% top-line growth from a year ago. That is modest progress, and a step down from the $17.16 billion IBM booked last quarter. The whisper number of $2.91 sits only slightly above consensus, suggesting a mildly higher bar rather than a dramatically different one. The more telling tension is on the full-year line. IBM cut its 2026 revenue outlook to a range of $70.24 billion to $70.91 billion, down from more than $70.91 billion previously, yet consensus sits at $71.37 billion, above the top of management's range. Either analysts expect the slipped deals to snap back faster than IBM is promising, or estimates have not fully caught up with the cut. Any guidance reaffirmation near the low end would expose that gap.

Software is where the story will be won or lost. Growth slowed to 5% last quarter and was flat organically, while transaction processing fell 9%, and IBM trimmed its software growth outlook to 6% to 8% from 10% plus. Management also pushed transaction processing monetization into 2027 and said its low-end guidance assumes the hardware-first spending pattern persists through the second half. Confirmation would look like a rebound in transaction processing as license deals close, continued acceleration at Red Hat after it improved to 11%, and steady growth in annual recurring revenue, which stood at $24.6 billion. A second consecutive quarter of flat organic software, or vague commentary on how many slipped deals actually landed, would undercut the deferral argument. Currency, now a 1.5-point headwind versus earlier assumptions, adds a further drag that could muddy reported growth.

There are offsetting strengths. IBM raised its infrastructure outlook to low-single-digit growth even as the mainframe cycle wraps against tough comparisons, and distributed infrastructure posted a record quarter with its highest-ever backlog of about $500 million. Consulting signings grew 6% for a second straight quarter, with generative AI making up about half. Management also held its target for roughly 100 basis points of pre-tax margin expansion despite the revenue miss, so margin delivery matters for the EPS line. Early traction for Project Lightwell, the new open-source remediation subscription aimed at large banks, would help show that newer catalysts can fill the software gap.

Investors appear to be giving IBM the benefit of the doubt. The stock has gained 12% since the last report, outpacing the S&P 500 by nearly 7 points, and sentiment has improved to modestly bullish from essentially neutral a quarter ago. Still, at about $227 the shares sit well below their 200-day moving average near $253 and in the middle of a post-earnings range between roughly $199 and $252, far beneath last quarter's peak above $330. The rebound looks like repair, not renewed conviction.

Ultimately, this report hinges on whether software growth reaccelerates as slipped deals close. If IBM shows those contracts landing and keeps its margin promise, the guidance cut looks like a timing hiccup. If not, the gap between Street forecasts and management's lowered range becomes the next problem.